Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Multidrug efflux pump subunit AcrB is the essential inner membrane component of the AcrAB-TolC system, the primary multidrug efflux pump in Gram-negative bacteria such as Escherichia coli (UniProt Consortium, 2023). It belongs to the Resistance-Nodulation-Division (RND) family and functions as a proton-motive force-dependent transporter that actively expels a wide variety of toxic compounds, including antibiotics, detergents, and dyes (Nikaido & Takatsuka, 2009). AcrB operates as a homotrimer, where each monomer cycles through three distinct conformational states—access, binding, and extrusion—to facilitate the peristaltic movement of substrates from the periplasm to the TolC exit duct (Yamaguchi et al., 2015). This efflux activity is a major driver of clinical multidrug resistance, as it prevents antibiotics like fluoroquinolones and beta-lactams from reaching their intracellular targets (Venter et al., 2015). Consequently, AcrB is a high-priority target for the development of efflux pump inhibitors (EPIs) like PAβN and D13-9001, which aim to restore antibiotic susceptibility (Nakashima et al., 2013). However, the development of these inhibitors faces challenges such as potential toxicity to host cells and the need for high potency to overcome the pump's high capacity (Opperman & Nguyen, 2015).
Efflux pump inhibition (EPI)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multidrug efflux pump subunit AcrB (AcrB).